GSK reportedly being investigated for Mideast behavior

Share this article:

The Wall Street Journal reported Sunday that GlaxoSmithKline is allegedly being investigated over unethical behavior in the Middle East. The WSJ says it has seen emails with allegations that track closely with previous allegations of improper behavior in China that plagued the company over the last year.

An inside source tells the paper that he believes GSK “practices in Iraq violate the FCPA and the UK Bribery Act.” FCPA refers to the US Foreign Corrupt Practices Act. Allegations include paying government-supported healthcare providers to double as sales representatives and providing “high fees...in exchange for promoting and prescribing its drugs.”

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.